QUOIN PHARMACEUTICALS LT-ADR (QNRX) Stock Analyst Ratings
NASDAQ:QNRX - Nasdaq - US74907L3006 - ADR
ChartMill assigns a Buy % Consensus number of 83% to QNRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.59. This target is 647.56% above the current price.
QNRX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QNRX.
In the previous month the buy percentage consensus was at a similar level.
QNRX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-15 | Maxim Group | Maintains | Buy -> Buy |
| 2022-09-07 | Alliance Global Partners | Initiate | Buy |
| 2022-05-06 | Ladenburg Thalmann | Initiate | Buy |
| 2022-01-07 | Maxim Group | Initiate | Buy |
| 2021-12-15 | JMP Securities | Initiate | Market Outperform |